Undergraduate Nursing Intern Cohort Study

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Occupational Disidentification Sponsors: Nanjing Medical University Recruiting Conditions: Occupational Disidentification Sponsors: Nanjing Medical University Recruiting 

Butyrate or Intensive Lifestyle Modification in Type 1 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Type 1 Diabetes Interventions: Other: Intensive lifestyle modification (hypocaloric Mediterranean diet and promotion of physical activity); Dietary Supplement: Butyrate; Dietary Supplement: Intensive lifestyle modification + butyrate Sponsors: Fundación...

Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Trisomy 8 Mosaicism; Trisomy 8 Associated Autoinflammatory Disease; Mucosal Ulcerations Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting Conditions: Trisomy 8 Mosaicism; Trisomy 8 Associated Autoinflammatory Disease;...

Extended Post-operative Oral TXA in Primary THA

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Osteoarthritis (OA) of the Hip; Osteoarthritis (OA) of the Knee Interventions: Drug: Extended oral tranexamic acid regimen; Drug: Placebo Sponsors: Oregon Health and Science University Not yet recruiting Conditions: Osteoarthritis (OA) of the Hip;...

A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Vitiligo Interventions: Drug: MH004 1.0% Ointment; Drug: MH004 Placebo Ointment Sponsors: Minghui Pharmaceutical (Hangzhou) Ltd Not yet recruiting Conditions: Vitiligo Interventions: Drug: MH004 1.0% Ointment; Drug: MH004 Placebo Ointment Sponsors:...

Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Autoimmune Encephalitis (AE); Autoimmune Cerebellitis Interventions: Drug: Blinatumomab Sponsors: Beijing Tiantan Hospital Not yet recruiting Conditions: Autoimmune Encephalitis (AE); Autoimmune Cerebellitis Interventions: Drug: Blinatumomab Sponsors:...